[PRESS RELEASE – SINGAPORE, SINGAPORE, May 14th, 2024] Vyvo Smart Chain, a HealthFi ecosystem that rewards health tracking through data monetization, today announced that Vyvo has received U.S. Food and Drug Administration (FDA) clearance for LifeWatch, the company’s innovative wearable device for health & wellness tracking. This achievement marks a significant leap forward in the convergence of blockchain technology and health monitoring. Vyvo’s LifeWatch pioneers a new era in health and wellness. LifeWatch promotes a user-centric health monitoring model and leverages Decentralized Physical Infrastructure network (DePIN) technology to allow users to monetize their health data. This ensures privacy, anonymity, and full ownership and control over personal health data,
Topics:
Chainwire considers the following as important: Press Release
This could be interesting, too:
Chainwire writes BYDFi Launches SUNDOG USDT-M Contracts for Traders
Chainwire writes PNUT Token: From Dispute to Market Recognition, Now Available on BYDFi
Chainwire writes SUI Meme Project Suirum Set To Launch On Cetus Protocol As The Presale Raises 67,000 $SUI
Chainwire writes Bitcoin L2 Labs Launches to Accelerate Core Development for Stacks, the Leading Bitcoin Layer 2
[PRESS RELEASE – SINGAPORE, SINGAPORE, May 14th, 2024]
Vyvo Smart Chain, a HealthFi ecosystem that rewards health tracking through data monetization, today announced that Vyvo has received U.S. Food and Drug Administration (FDA) clearance for LifeWatch, the company’s innovative wearable device for health & wellness tracking. This achievement marks a significant leap forward in the convergence of blockchain technology and health monitoring.
Vyvo’s LifeWatch pioneers a new era in health and wellness. LifeWatch promotes a user-centric health monitoring model and leverages Decentralized Physical Infrastructure network (DePIN) technology to allow users to monetize their health data. This ensures privacy, anonymity, and full ownership and control over personal health data, empowering users to securely manage and monetize their information.
Fabio Galdi, Co-Founder and CEO of Vyvo, stated, “This approval marks a significant advancement in integrating blockchain technology into health and wellness. Our commitment is to innovation and user empowerment, and this FDA clearance positions us to continue challenging the current norms and lead a transformation in health solutions.”
Vyvo’s FDA clearance highlights the reliability and innovation of LifeWatch, offering users unparalleled convenience and accuracy in monitoring vital signs. This clearance underscores the dependability of Vyvo’s devices, providing users peace of mind with precise readings essential for maintaining optimal health. In an era where quick and accurate health assessments are crucial, Vyvo’s FDA-cleared devices offer a solution that provides real-time insights into metrics such as heart rate, blood pressure, stress and energy levels.
Vyvo not only empowers users with advanced wellness monitoring tools but also fosters a secure and transparent ecosystem for health data, powered by blockchain technology. By continually pushing the boundaries of digital health management, Vyvo opens up new avenues for individuals to take charge of their well-being.
Vyvo’s wearable devices are available at helohealth.com. To learn more about VSC and earning rewards through health tracking, users can visit vyvo.com.
About Vyvo Smart Chain
Vyvo Smart Chain is a HealthFi ecosystem that rewards health tracking through data monetization on IoT devices. Vyvo makes it easy for people to understand and track their body stats, secure health data privacy and earn rewards for doing so while contributing to research into new drugs, developing treatments, and preventing the spread of diseases.